## Abstract The proβinflammatory cytokine interleukinβ1 (ILβ1), contributes to neuronal inflammation and cell death induced by ischemia, excitotoxicity, or trauma, while administration of ILβ1 receptor antagonist (ILβ1ra) reduces neuronal injury. The aim of the present study was to test the hypothe
Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease
β Scribed by Robert C. Thompson; David J. Dripps; Stephen P. Eisenberg
- Publisher
- Elsevier Science
- Year
- 1992
- Tongue
- English
- Weight
- 459 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Interleukin (IL)-1-like protein 1 (IL-1L1) is a 155-amino acid protein that shares 27% identity with IL-1 g and 47% with IL-1 receptor antagonist (IL-1ra). A 2.7-kb IL-1L1 mRNA was cloned from human placenta and is detectable in the trophoblastic cell line JEG-3, in macrophages and in endotoxin-stim
Three molecular forms of the IL-1 receptor antagonist (IL-1ra) have been identified and cloned. Secreted IL-1ra (sIL-1ra or IL-1ra1) contains a classical leader peptide giving a released mature protein. Two intracellular isoforms, icIL-1ra type I (IL-1ra2) and icIL-1ra type II (IL-1ra3), have no lea